×

Novo Nordisk A/S - Reduction of the share capital

BAGSVAERD, Denmark, April 22, 2015 (GLOBE NEWSWIRE) -- At Novo Nordisk's Annual General Meeting on 19 March 2015, it was decided to reduce the company's B share capital from DKK 422,512,800 to DKK 412,512,800 by cancellation of part of the company's portfolio of own B shares at a nominal value of DKK 10,000,000 divided into 50,000,000 B shares of DKK 0.20 each.

Further information

Media:
Anne Margrethe Hauge +45 3079 3450 amhg@novonordisk.com


Investors:
Kasper Roseeuw Poulsen +45 3079 4303 krop@novonordisk.com
Daniel Bohsen +45 3079 6376 dabo@novonordisk.com
Melanie Raouzeos +45 3075 3479 mrz@novonordisk.com
Frank Daniel Mersebach (US) +1 609 235 8567 fdni@novonordisk.com

Company announcement No 27 / 2015

Company announcement no 27 / 2015 http://hugin.info/2013/R/1913419/683321.pdf

HUG#1913419

Source:Novo Nordisk A/S